1-10 of 10
Bernhard Wörmann
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A New Molecular and Clinical Prognostic Score for Risk Stratification in CN-AML.

Friederike Schneider, Annika Dufour, Tobias Benthaus, Stephanie Schneider, Gudrun Mellert, Evelyn Zellmeier, Stefan K Bohlander, Michael Unterhalt, Michaela Feuring-Buske, Christian Buske, Jan Braess, Maria Cristina Sauerland, Achim Heinecke, Wolfgang Berdel, Thomas Buechner, Bernhard Wörmann, Wolfgang Hiddemann, Karsten Spiekermann, Eva Hoster
Journal: Blood
Blood (2009) 114 (22): 2635.
https://doi.org/10.1182/blood.V114.22.2635.2635
Published: 2009
Journal Articles

Continuous Decrease of Overall Survival in Patients > 30 Years of Age with Acute Myelogenous Leukemia.

Utz O. Krug, MD, Wolfgang Berdel, MD, Susanne Amler, Maria C. Sauerland, PhD, Bernhard Wörmann, MD, Wolfgang Hiddemann, MD, Thomas Buchner, MD
Journal: Blood
Blood (2009) 114 (22): 998.
https://doi.org/10.1182/blood.V114.22.998.998
Published: 2009
Journal Articles

Autologous Stem Cell Transplantation and Addition of Rituximab Independently Prolong Response Duration in Advanced Stage Mantle Cell Lymphoma.

Eva Hoster, Bernd Metzner, Roswitha Forstpointner, Michael Pfreundschuh, Lorenz Trümper, Michael Hallek, Bernhard Wörmann, Ulrich Dührsen, MD, Christian Gisselbrecht, Hanneke C. Kluin-Nelemans, Achiel Van Hoof, Michael Unterhalt, Wolfgang Hiddemann, Martin H. Dreyling
Journal: Blood
Blood (2009) 114 (22): 880.
https://doi.org/10.1182/blood.V114.22.880.880
Published: 2009
Journal Articles

The Addition of Rituximab to First-Line Chemotherapy (R-CHOP) Results in Superior Response Rates, Time to Treatment Failure and Response Duration in Patients with Advanced Stage Mantle Cell Lymphoma: Long Term Results of a Randomized GLSG Trial

Eva Hoster, Michael Unterhalt, PhD, Bernhard Wörmann, Ulrich Dührsen, Bernd Metzner, Hartmut Eimermacher, Andreas Neubauer, Hannes Wandt, Hjalmar Steinhauer, Sonja Martin, Else Heidemann, Ali Aldaoud, Wolfgang Hiddemann, Martin Dreyling
Journal: Blood
Blood (2008) 112 (11): 3049.
https://doi.org/10.1182/blood.V112.11.3049.3049
Published: 2008
Journal Articles

An 86-Probe Gene Expression Signature Can Predict Survival in AML with Normal Karyotype Independently of FLT3 ITD and NPM1 Mutation Status - A Collaborative Study from the AMLCG and CALGB Study Groups.

Klaus H. Metzeler, Manuela Hummel, Clara D. Bloomfield, Karsten Spiekermann, Maria C. Sauerland, Achim Heinecke, Michael Radmacher, Guido Marcucci, Susan P. Whitman, Kati Maharry, Peter Paschka, Richard A. Larson, Wolfgang E. Berdel, Thomas Büchner, Bernhard Wörmann, Ulrich Mansmann, Wolfgang Hiddemann, Stefan K. Bohlander, Christian Buske
Journal: Blood
Blood (2007) 110 (11): 596.
https://doi.org/10.1182/blood.V110.11.596.596
Published: 2007
Journal Articles

Prognosis of AML with Unfavourable Cytogenetics Treated with Intensive Double Induction Chemotherapy: An Analysis of 342 Patients from the German AMLCG-2000 Study.

Klaus H. Metzeler, Christian Buske, Jan Braess, Karsten Spiekermann, Michaela Feuring-Buske, Stefan K. Bohlander, Michael Unterhalt, Maria-Cristina Sauerland, Wolfgang E. Berdel, Bernhard Wörmann, Achim Heinecke, Thomas Büchner, Wolfgang Hiddemann
Journal: Blood
Blood (2006) 108 (11): 2006.
https://doi.org/10.1182/blood.V108.11.2006.2006
Published: 2006
Journal Articles

Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group

Clinical Trials & Observations
Wolfgang Hiddemann, Michael Kneba, Martin Dreyling, Norbert Schmitz, Eva Lengfelder, Rudolf Schmits, Marcel Reiser, Bernd Metzner, Harriet Harder, Susanna Hegewisch-Becker, Thomas Fischer, Martin Kropff, Hans-Edgar Reis, Mathias Freund, Bernhard Wörmann, Roland Fuchs, Manfred Planker, Jörg Schimke, Hartmut Eimermacher, Lorenz Trümper, Ali Aldaoud, Reza Parwaresch, Michael Unterhalt
Journal: Blood
Blood (2005) 106 (12): 3725–3732.
https://doi.org/10.1182/blood-2005-01-0016
Published: 2005
Journal Articles

Double Induction Strategy for Acute Myeloid Leukemia: The Effect of High-Dose Cytarabine With Mitoxantrone Instead of Standard-Dose Cytarabine With Daunorubicin and 6-Thioguanine: A Randomized Trial by the German AML Cooperative Group

Thomas Büchner, Wolfgang Hiddemann, Bernhard Wörmann, Helmut Löffler, Winfried Gassmann, Torsten Haferlach, Christa Fonatsch, Detlef Haase, Claudia Schoch, Dieter Hossfeld, Eva Lengfelder, Carlo Aul, Axel Heyll, Georg Maschmeyer, Wolf-Dieter Ludwig, Maria-Cristina Sauerland, Achim Heinecke
Journal: Blood
Blood (1999) 93 (12): 4116–4124.
https://doi.org/10.1182/blood.V93.12.4116
Published: 1999
Journal Articles

Partial Tandem Duplications of the MLL Gene Are Detectable in Peripheral Blood and Bone Marrow of Nearly All Healthy Donors

Susanne Schnittger, Bernhard Wörmann, Wolfgang Hiddemann, Frank Griesinger
Journal: Blood
Blood (1998) 92 (5): 1728–1734.
https://doi.org/10.1182/blood.V92.5.1728
Published: 1998
Journal Articles

Activity of Thymidine Kinase and of Polymerase α as Well as Activity and Gene Expression of Deoxycytidine Deaminase in Leukemic Blasts Are Correlated With Clinical Response in the Setting of Granulocyte-Macrophage Colony-Stimulating Factor–Based Priming Before and During TAD-9 Induction Therapy in Acute Myeloid Leukemia

Gerlinde Jahns-Streubel, Christoph Reuter, Ulrike Auf der Landwehr, Michael Unterhalt, Eberhard Schleyer, Bernhard Wörmann, Thomas Büchner, Wolfgang Hiddemann
Journal: Blood
Blood (1997) 90 (5): 1968–1976.
https://doi.org/10.1182/blood.V90.5.1968
Published: 1997